MRC1 and neoplasm: However, in our models, 90% of CD206+ cells in the tumor microenvironment are F4/80‐positive cells (Figure S8, Supporting Information), i.e., belonging to the monocyte‐macrophage lineage, suggesting that the main biological impact of CD206‐targeting derives prevalently from targeting TAM rather than dendritic cells.